Evolving Frontiers of Quality Risk Management: Tools, Principles, and Practice in the Pharmaceutical Sector

Abstract

Quality Risk Management (QRM) is a vital component of pharmaceutical quality systems, ensuring product safety and efficacy throughout the lifecycle. This review highlights the evolution of QRM from its origins in high-risk industries to its current application in the pharmaceutical and biopharmaceutical sectors. Emphasis is placed on regulatory guidance, particularly ICH Q9, which outlines a systematic approach to risk identification, assessment, control, communication, and review. Core principles of QRM include science-based decisions, patient protection, and proportional documentation. Key tools such as HAZOP, HACCP, Ishikawa diagrams, and risk matrices are explored, demonstrating their use in identifying and mitigating potential quality risks. Real-world case studies illustrate the practical application of QRM in areas like facility cleaning and equipment replacement. Overall, QRM supports proactive decision-making, improves regulatory compliance, and enhances product quality, making it an essential practice in pharmaceutical manufacturing and quality assurance.